Valeo Pharma (TSX:VPH) EPS (Basic) : C$-0.33 (TTM As of Jan. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Valeo Pharma EPS (Basic)?

Valeo Pharma's basic earnings per share (Basic EPS) for the three months ended in Jan. 2024 was C$-0.08. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jan. 2024 was C$-0.33.

Valeo Pharma's EPS (Diluted) for the three months ended in Jan. 2024 was C$-0.08. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 was C$-0.33.

Valeo Pharma's EPS without NRI for the three months ended in Jan. 2024 was C$-0.10. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jan. 2024 was -0.34.

During the past 3 years, the average EPS without NRI Growth Rate was -58.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was -51.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 7 years, Valeo Pharma's highest 3-Year average EPS without NRI Growth Rate was -20.60% per year. The lowest was -62.80% per year. And the median was -58.05% per year.

Valeo Pharma EPS (Basic) Historical Data

The historical data trend for Valeo Pharma's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valeo Pharma EPS (Basic) Chart

Valeo Pharma Annual Data

Trend

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

EPS (Basic)

Get a 7-Day Free Trial

-0.07

-0.08

-0.20

-0.32

Valeo Pharma Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
EPS (Basic)	Get a 7-Day Free Trial															-0.08	-0.08	-0.07	-0.10	-0.08

Valeo Pharma EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Valeo Pharma's Basic EPS for the fiscal year that ended in Oct. 2023 is calculated as

Basic EPS (A: Oct. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-27.808	-	0)	/	86.117
	=	-0.32

Valeo Pharma's Basic EPS for the quarter that ended in Jan. 2024 is calculated as

Basic EPS (Q: Jan. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-6.872	-	0)	/	86.138
	=	-0.08

EPS (Basic) for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.33

Valeo Pharma (TSX:VPH) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Valeo Pharma EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Valeo Pharma's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Valeo Pharma (TSX:VPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Valeo Pharma Inc (TSX:VPH) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

VPHIF:USA

Address

16667, Hymus Boulevard, Kirkland, QC, CAN, H9H 4R9

Website

https://www.valeopharma.com

Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and Niche hospital injectable products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.

Executives

Luc Mainville

Senior Officer

Valeo Pharma (TSX:VPH) Headlines

No Headlines